Skip to main content
. 2016 May 27;7(29):45370–45384. doi: 10.18632/oncotarget.9659

Table 2. Cox regression analysis of prognostic factors for overall CRC patient survival (n=188).

Clinicopathological features Univariate Analysis Multivariate Analysis
HR (95%Cl) P-value HR (95%Cl) P-value
miR-138-5p downregulation 0.466(0.274-0.790) 0.001* 0.493(0.273-0.890) 0.019*
Gender 0.688(0.402-1.176) 0.535
Age 0.677(0.465-1.241) 0.688
T status 1.605(0.969-2.658) 0.066 1.561(0.951-2.564) 0.078
Lymph node metastasis 1.990(1.393-2.841) <0.001* 1.831(1.296-2.587) 0.001*
M status 2.819(1.632-4.869) <0.001* 2.65(2.015-4.542) <0.001*
TNM stage 2.623(1.959-3.512) <0.001* 2.004(1.384-2.901) <0.001*
Dukes stage 2.793(2.093-3.728) <0.001* 2.113(1.492-2.992) <0.001*

CI = confidence interval; HR = hazard ratio

*

P<0.05.